Grants per year
Personal profile
Research Interests
Practice focused on diagnosis and comprehensive treatment of multiple sclerosis and related CNS demyelinating diseases. Research interests focused on novel clinical therapeutics for Multiple Sclerosis and related CNS Demyelinating diseases.
Certifications and Licenses
| Internal Medicine | |
| Neurology |
Training Experience
| 1981 | Residency, Lutheran General Hospital |
| 1984 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
Medicine, MD, University of Illinois at Chicago
… → 1978
Research interests keywords
- Autoimmune Diseases
- Multiple Sclerosis
Fingerprint
Dive into the research topics where Bruce Arnold Cohen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
North American Registry for Care and Research in Multiple Sclerosis (NARCRMS) Study
Consortium of Multiple Sclerosis Centers Inc.
9/1/18 → 8/31/24
Project: Research project
-
Prot# ALXN1210-NMO-307: A Phase 3, External Placebo-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
INC Research, LLC, Alexion Pharmaceuticals, Inc
2/18/21 → 2/17/22
Project: Research project
-
Prot# MD1003CT2016-01MS-SPI2: Effect of MD1003 in Progressive Multiple Sclerosis: A Randomized Double Blind Placebo Controlled Study
5/25/17 → 5/25/23
Project: Research project
-
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society
Miller, A. E., Chitnis, T., Cohen, B. A., Costello, K., Sicotte, N. L. & Stacom, R., Feb 2021, In: JAMA Neurology. 78, 2, p. 241-246 6 p.Research output: Contribution to journal › Review article › peer-review
28 Scopus citations -
Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study
on behalf of the SPRINT-MS investigators, Jan 26 2021, In: Neurology. 96, 4, p. E491-E500Research output: Contribution to journal › Article › peer-review
25 Scopus citations -
Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS
Freedman, M. S., Brod, S., Singer, B. A., Cohen, B. A., Hayward, B., Dangond, F. & Coyle, P. K., Jan 1 2020, In: Journal of Neurology. 267, 1, p. 64-75 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Cree, B. A. C., Cutter, G., Wolinsky, J. S., Freedman, M. S., Comi, G., Giovannoni, G., Hartung, H. P., Arnold, D., Kuhle, J., Block, V., Munschauer, F. E., Sedel, F., Lublin, F. D., Reingold, S., Duquette, P., Derfuss, T., Fazekas, F., Sormani, M. P., Lisak, R. P., Graves, J., & 94 others, Dec 2020, In: The Lancet Neurology. 19, 12, p. 988-997 10 p.Research output: Contribution to journal › Article › peer-review
58 Scopus citations -
Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis
Cohen, B. A., Feb 26 2019, In: Neurology. 92, 9, p. 435-436 2 p.Research output: Contribution to journal › Article › peer-review
29 Scopus citations